Literature DB >> 12137161

Duodenal stents for malignant duodenal strictures.

S D Johnston1, S T D McKelvey, R J Moorehead, R A J Spence, T C K Tham.   

Abstract

Duodenal obstruction may be caused by inoperable malignant disease. Symptoms of nausea and vomiting have been traditionally palliated by surgery. The aim of the study was to determine the efficacy of the endoscopic placement of metal self expanding duodenal stents for the palliation of malignant duodenal obstruction. Four patients with malignant gastric outlet obstruction are described. One patient had a history of oesophagectomy for oesophageal adenocarcinoma and presented with further dysphagia. At endoscopy the recurrent oesophageal tumour and an adenocarcinoma involving the pylorus were both stented. In the other three patients there was a previous history of colonic carcinoma, cholangiocarcinoma and oesophageal adenocarcinoma respectively. All four patients were successfully stented with good palliation of their symptoms. Duodenal Wallstents are a useful alternative to surgery in patients with inoperable malignant duodenal obstruction or those who are unfit for surgery.

Entities:  

Mesh:

Year:  2002        PMID: 12137161      PMCID: PMC2475353     

Source DB:  PubMed          Journal:  Ulster Med J        ISSN: 0041-6193


  11 in total

1.  Gastric and duodenal stents: follow-up and complications.

Authors:  I T Pinto Pabón; L P Díaz; J C Ruiz De Adana; J López Herrero
Journal:  Cardiovasc Intervent Radiol       Date:  2001 May-Jun       Impact factor: 2.740

2.  Palliation of obstructing gastric cancer with steel mesh, self-expanding endoprostheses.

Authors:  M Topazian; E Ring; J Grendell
Journal:  Gastrointest Endosc       Date:  1992 Jan-Feb       Impact factor: 9.427

3.  Nonsurgical bypass of malignant duodenal and biliary obstruction.

Authors:  S K Buto; T K Tsang; A R Crampton; G Berlin
Journal:  Gastrointest Endosc       Date:  1990 Sep-Oct       Impact factor: 9.427

4.  Fluoroscopic-guided covered metallic stent placement for gastric outlet obstruction and post-operative gastroenterostomy anastomotic stricture.

Authors:  J M Lee; Y M Han; C S Kim; S Y Lee; S T Lee; D H Yang
Journal:  Clin Radiol       Date:  2001-07       Impact factor: 2.350

Review 5.  Peroral insertion techniques of self-expanding metal stents for malignant gastric outlet and duodenal stenoses.

Authors:  I Maetani; H Inoue; M Sato; S Ohashi; Y Igarashi; Y Sakai
Journal:  Gastrointest Endosc       Date:  1996-10       Impact factor: 9.427

6.  Relief of malignant duodenal obstruction by percutaneous insertion of a metal stent.

Authors:  M Keymling; H J Wagner; N Vakil; K Knyrim
Journal:  Gastrointest Endosc       Date:  1993 May-Jun       Impact factor: 9.427

7.  Clinical outcome of the use of enteral stents for palliation of patients with malignant upper GI obstruction.

Authors:  H B Yim; B C Jacobson; J R Saltzman; R S Johannes; B C Bounds; J H Lee; S J Shields; F W Ruymann; J Van Dam; D L Carr-Locke
Journal:  Gastrointest Endosc       Date:  2001-03       Impact factor: 9.427

8.  Gastrojejunostomy: is it helpful for patients with pancreatic cancer?

Authors:  D W Weaver; R G Wiencek; D L Bouwman; A J Walt
Journal:  Surgery       Date:  1987-10       Impact factor: 3.982

9.  Palliation of malignant gastric outlet obstruction using an endoscopically placed Wallstent.

Authors:  R M Soetikno; D R Lichtenstein; J Vandervoort; R C Wong; A D Roston; A Slivka; H Montes; D L Carr-Locke
Journal:  Gastrointest Endosc       Date:  1998-03       Impact factor: 9.427

10.  Self-expanding metal stents for palliative treatment of malignant biliary and duodenal stenoses.

Authors:  I Maetani; S Ogawa; H Hoshi; M Sato; H Yoshioka; Y Igarashi; Y Sakai
Journal:  Endoscopy       Date:  1994-10       Impact factor: 10.093

View more
  1 in total

1.  Retrospective evaluation of endoscopic stenting of combined malignant common bile duct and gastric outlet-duodenum obstructions.

Authors:  Jianfeng Yu; Jianyu Hao; Dongfang Wu; Haibo Lang
Journal:  Exp Ther Med       Date:  2014-08-11       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.